Search Results for citation:"90 FR 16555"

Found 2 results
Skip to main content

Search Results: citation:"90 FR 16555"

  • Type:Notice
    Citation:90 FR 16555
    Reading Time:about a minute or two

    Myonex LLC has submitted an application to the Drug Enforcement Administration (DEA) to become a registered importer of certain controlled substances. The company plans to import these substances in dosage forms specifically for use in clinical trials, research, and analytical work, but not for commercial sales. Interested parties, including manufacturers or other applicants, are invited to submit comments or objections to this application by May 19, 2025, and they also have the option to request a hearing. No commercial activities involving the finished dosage forms are allowed under this registration.

    Simple Explanation

    Myonex LLC wants permission to bring in certain special medicines from outside the country to use for tests and studies, but not to sell. People who might worry about this can say something about it by May 19, 2025.

  • Type:Notice
    Citation:90 FR 16555
    Reading Time:about a minute or two

    Stepan Company has applied to the Drug Enforcement Administration (DEA) to become a bulk manufacturer of certain controlled substances. This request was made on January 31, 2025, and is currently open for public comment until June 17, 2025. Individuals who are already registered manufacturers of these substances or are applicants for such a registration can submit their comments or objections electronically through the Federal eRulemaking Portal. Interested parties may also request a hearing on this application before the deadline if desired.

    Simple Explanation

    Stepan Company wants permission to make certain special substances, and people can say if they think it's a good or bad idea until June 17, 2025, but we don't know which substances or how this decision might affect others.